Hiroaki Hamada
-
- Colorectal Cancer Screening and Detection 5
-
- Cancer, Lipids, and Metabolism 2
-
- Genetic factors in colorectal cancer 3
-
- Vasculitis and related conditions 3
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
-
- Blood disorders and treatments 2
-
- Adipose Tissue and Metabolism 2
-
- Receptor Mechanisms and Signaling 2
- Co-authors
- Suminori KonoHiroko KogaHitomi HayabuchiKoichi HandaChikako KiyoharaHisako InoueTomomi MarugameKazuya Onuma
- Partner nations
- JapanUnited States
In The Last Decade
Hiroaki Hamada
18 papers receiving 378 citations
Peers
Comparison fields: 5 of 59
- Oncology 158
- Cancer Research 83
- Pathology and Forensic Medicine 89
- Rheumatology 56
- Endocrinology, Diabetes and Metabolism 42
Countries citing papers authored by Hiroaki Hamada
This map shows the geographic impact of Hiroaki Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Hamada more than expected).
Fields of papers citing papers by Hiroaki Hamada
This network shows the impact of papers produced by Hiroaki Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Hamada. The network helps show where Hiroaki Hamada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroaki Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 2 | |
| 2 | 2016 | 5 | |
| 3 | 2015 | 1 | |
| 4 | 2010 | 5 | |
| 5 | 2006 | 2 | |
| 6 | 2005 | 1 | |
| 7 | 2005 | 1 | |
| 8 | 2001 | 44 | |
| 9 | 2001 | 26 | |
| 10 | 2000 | 50 | |
| 11 | Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas. | 2000 | 42 |
| 12 | 1999 | 104 | |
| 13 | 1999 | 29 | |
| 14 | 1999 | 18 | |
| 15 | 1998 | 51 | |
| 16 | 1997 | 10 | |
| 17 | 1997 | 4 | |
| 18 | 1994 | 4 |
About Hiroaki Hamada
Hiroaki Hamada is a scholar working on Acoustics and Ultrasonics, Transplantation, Pathology and Forensic Medicine, Oncology and Physiology, having authored 18 papers that have together received 399 indexed citations. Recurring topics across this work include Colorectal Cancer Screening and Detection (5 papers), Genetic factors in colorectal cancer (3 papers), Vasculitis and related conditions (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Cancer, Lipids, and Metabolism (2 papers), Blood disorders and treatments (2 papers), Adipose Tissue and Metabolism (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Oncology (158 citations), Cancer Research (83 citations), Pathology and Forensic Medicine (89 citations), Rheumatology (56 citations) and Endocrinology, Diabetes and Metabolism (42 citations). Hiroaki Hamada has collaborated with scholars based in Japan and United States. Frequent co-authors include Suminori Kono, Hiroko Koga, Hitomi Hayabuchi, Koichi Handa, Chikako Kiyohara, Hisako Inoue, Tomomi Marugame, Kazuya Onuma, Masato Nishiwaki and Emiko Tsuji. Their work appears in journals such as Modern Rheumatology, Cancer Letters, Annals of Epidemiology, Cancer Causes & Control and European Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.